UBS Initiates Coverage On Twist Bioscience with Neutral Rating, Announces Price Target of $144
UBS analyst Doug Schenkel initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Neutral rating and announces Price Target of $144.
A big bank's analyst started watching Twist Bioscience and thinks it's worth around $144 per share, but isn't saying it's a great buy or a bad buy right now. When an expert starts paying attention to a company, it's worth noticing what they think, even if they're unsure about which way things will go.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.